Antimicrobial Resistance (AMR): Chemistry Solutions Beyond Traditional Antibiotics

Antimicrobial resistance (AMR) has emerged as the most critical threat to global health, contributing to over 1.2 million deaths annually and projected to cause up to 10 million deaths per year by 2050 if left unaddressed. Traditional antibiotic development focused on structural modification of existing molecules has failed to match the rapid evolution of resistance mechanisms. This review underscores a paradigm shift, positioning chemistry not as a supplementary tool but as a transformative force in AMR mitigation. We explore a spectrum of chemistry-driven strategies, including efflux pump inhibitors that restore antibiotic efficacy by over 80% in vitro, β-lactamase inhibitors with 50–90% re-sensitization capacity, and antisense oligonucleotides demonstrating >70% gene silencing efficiency for resistance determinants like blaCTX-M and ndm-1. Novel CRISPR-based antimicrobials delivered via chemically engineered nanoparticles have shown the potential to restore colistin susceptibility in >60% of resistant strains. Furthermore, smart nanomaterials and targeted delivery systems have achieved up to 5-fold increases in localized drug concentration, significantly reducing off-target effects. These precision-based approaches enabled by synthetic chemistry, materials science, and molecular engineering offer versatile, adaptable, and resistance-mitigating solutions. We highlight regulatory challenges, scalability concerns, and the imperative for interdisciplinary collaboration to bridge lab innovations with clinical implementation. Chemistry remains central in the quest for sustainable, long-term solutions to AMR.